Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
AI-Driven Automation
72% of Business Leaders Want AI Adoption Within 3 Years: Weekly Stat
New data suggests that leaders are highly interested in AI but must plan around the risks associated with adoption.
By
Adam Zaki
| May 31, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
AI-Driven Automation
72% of Business Leaders Want AI Adoption Within 3 Years: Weekly Stat
New data suggests that leaders are highly interested in AI but must plan around the risks associated with adoption.
By
Adam Zaki
| May 31, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
drug prices
Risk & Compliance
Pelosi’s Drug Plan Would Save Medicare $345B
House Democrats say a CBO analysis shows the bill will "rein in the soaring cost of prescription drugs and level the playing field for American patients."
By
Matthew Heller
| October 15, 2019
Read More
Human Capital & Careers
Companies Plead for New Pharma Supply Model
The long-entrenched system of drug-manufacturer rebates has not adapted to changes in health-plan designs and labor-market trends.
By
David McCann
| August 8, 2018
Read More
M&A
Icahn Blasts Cigna Deal for PBM as ‘Travesty’
The investor urges Cigna shareholders to reject the acquisition of Express Scripts, calling it potentially “one of the worst blunders in corporate history."
By
Matthew Heller
| August 7, 2018
Read More
